NASDAQ:MTLS - Materialise Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $25.00
  • Forecasted Upside: 70.88 %
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$14.63
▲ +1.12 (8.29%)

This chart shows the closing price for MTLS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Materialise Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MTLS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MTLS

Analyst Price Target is $25.00
▲ +70.88% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Materialise in the last 3 months. The average price target is $25.00, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 70.88% upside from the last price of $14.63.

This chart shows the closing price for MTLS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 4 contributing investment analysts is to buy stock in Materialise. This rating has held steady since August 2021, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
1/12/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
4/12/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
7/11/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/9/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/7/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/7/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/6/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/6/2022

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/3/2022Stifel NicolausLower Price Target$26.00 ➝ $22.00Low
4/27/2022Stifel NicolausLower Price Target$30.00 ➝ $26.00Medium
3/25/2022Bryan, Garnier & CoDowngradeBuy ➝ Neutral$20.00Low
10/20/2021JPMorgan Chase & Co.Initiated CoverageOverweight$28.00Low
9/2/2021Stifel NicolausInitiated CoverageBuy$30.00High
8/9/2021Lake Street CapitalInitiated CoverageBuy$30.00Medium
3/10/2021Bryan, Garnier & CoUpgradeNeutral ➝ Buy$43.00High
10/30/2020Piper SandlerReiterated RatingNeutral$38.00High
7/30/2020Kepler Capital MarketsDowngradeSell$15.00High
5/5/2020Kepler Capital MarketsDowngradeSell$15.00Medium
4/30/2020Piper SandlerLower Price TargetNeutral$15.50 ➝ $14.50Medium
4/7/2020Piper SandlerDowngradeOverweight ➝ Neutral$20.00 ➝ $15.50High
3/12/2020Kepler Capital MarketsUpgradeHold$16.25High
3/4/2020Kepler Capital MarketsDowngradeSell$15.49High
3/4/2020Piper SandlerLower Price Target$22.00 ➝ $20.00High
3/7/2019Piper Jaffray CompaniesReiterated RatingOverweight$19.00High
12/28/2018KBC SecuritiesDowngradeBuy ➝ Hold$20.07Medium
11/10/2017KeyCorpReiterated RatingBuy$18.00N/A
10/13/2017Piper Jaffray CompaniesReiterated RatingBuy$20.00N/A
8/11/2017Credit Suisse GroupBoost Price TargetOutperform$13.00 ➝ $14.00Low
7/31/2017Piper Jaffray CompaniesBoost Price TargetOverweight$18.50Low
(Data available from 7/6/2017 forward)

News Sentiment Rating

0.09 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 6 very positive mentions
  • 7 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
12/8/2021
  • 4 very positive mentions
  • 6 positive mentions
  • 5 negative mentions
  • 1 very negative mentions
1/7/2022
  • 4 very positive mentions
  • 13 positive mentions
  • 8 negative mentions
  • 1 very negative mentions
2/6/2022
  • 2 very positive mentions
  • 19 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
3/8/2022
  • 3 very positive mentions
  • 4 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
4/7/2022
  • 2 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
5/7/2022
  • 4 very positive mentions
  • 11 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
6/6/2022
  • 2 very positive mentions
  • 14 positive mentions
  • 2 negative mentions
  • 3 very negative mentions
7/6/2022

Current Sentiment

  • 2 very positive mentions
  • 14 positive mentions
  • 2 negative mentions
  • 3 very negative mentions
Materialise logo
Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. Its Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. The company's Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. Its Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.
Read More

Today's Range

Now: $14.63
Low: $13.02
High: $14.63

50 Day Range

MA: $14.64
Low: $12.62
High: $17.48

52 Week Range

Now: $14.63
Low: $12.44
High: $27.55

Volume

285,832 shs

Average Volume

268,422 shs

Market Capitalization

$792.49 million

P/E Ratio

44.33

Dividend Yield

N/A

Beta

0.76

Frequently Asked Questions

What sell-side analysts currently cover shares of Materialise?

The following Wall Street analysts have issued reports on Materialise in the last twelve months: Bryan, Garnier & Co, JPMorgan Chase & Co., Lake Street Capital, Stifel Nicolaus, StockNews.com, and TheStreet.
View the latest analyst ratings for MTLS.

What is the current price target for Materialise?

0 Wall Street analysts have set twelve-month price targets for Materialise in the last year. Their average twelve-month price target is $25.00, suggesting a possible upside of 70.9%.
View the latest price targets for MTLS.

What is the current consensus analyst rating for Materialise?

Materialise currently has 1 hold rating and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe MTLS will outperform the market and that investors should add to their positions of Materialise.
View the latest ratings for MTLS.

How do I contact Materialise's investor relations team?

Materialise's physical mailing address is TECHNOLOGIELAAN 15, LEVUEN C9, 3001. The software maker's listed phone number is (321) 639-6611 and its investor relations email address is [email protected] The official website for Materialise is www.materialise.com. Learn More about contacing Materialise investor relations.